Federal award
MAPP BIOPHARMACEUTICAL, INC.
W911QY14P0232
ContractSBIR/STTR SR1
Obligated and Ceiling
- Obligated (net)
- $149,876.77
- Ceiling (potential value, not spending)
- $149,876.77
- Current value
- $149,876.77
- Gross positive obligations
- $149,876.77
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- W911QY14P0232
- Award type code
- B
- Actions
- 3 · Jun 13, 2014 to Feb 26, 2016
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History3
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 26, 2016 | FY2016 | P00002 | G | $49,927.41 | — |
| Aug 19, 2014 | FY2014 | P00001 | B | $0.00 | — |
| Jun 13, 2014 | FY2014 | 0 | — | $99,949.36 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.